/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for Coley Pharmaceutical Group Inc.\n \n\n\n\n\n
Nov 22 8:13 PM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n Jan 04, 2008 5:35 PM EST
\n\n \n QED International Associates Announces Changes to the HealthShares(TM) Emerging Cancer Index - PR Newswire\n \n \n
\n\n Nov 26, 2007 1:29 PM EST
\n\n \n Coley Pharmaceutical Group to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference - PR Newswire\n \n \n
\n\n Nov 01, 2007 4:06 PM EDT
\n\n \n Coley Pharmaceutical Group Reports Third Quarter and Nine-month Financial Results - PR Newswire\n \n \n
\n\n Oct 31, 2007 2:25 PM EDT
\n\n \n Coley Pharmaceutical Group to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference - PR Newswire\n \n \n
\n\n Oct 30, 2007 9:02 AM EDT
\n\n \n Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development - PR Newswire\n \n \n
\n\n Oct 29, 2007 9:02 AM EDT
\n\n \n Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus - PR Newswire\n \n \n
\n\n Oct 26, 2007 11:35 AM EDT
\n\n \n Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline - PR Newswire\n \n \n
\n
\n\n");